Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $2,752 - $3,180
10 Added 0.81%
1,240 $353,000
Q1 2023

May 10, 2023

BUY
$256.56 - $292.34 $315,568 - $359,578
1,230 New
1,230 $341,000
Q2 2020

Aug 05, 2020

SELL
$258.66 - $342.55 $186,752 - $247,321
-722 Closed
0 $0
Q1 2020

May 06, 2020

SELL
$268.85 - $341.04 $200,024 - $253,733
-744 Reduced 50.75%
722 $228,000
Q4 2019

Feb 07, 2020

SELL
$220.06 - $304.07 $13,863 - $19,156
-63 Reduced 4.12%
1,466 $435,000
Q3 2019

Nov 04, 2019

BUY
$217.44 - $243.88 $66,319 - $74,383
305 Added 24.92%
1,529 $356,000
Q2 2019

Aug 07, 2019

SELL
$219.29 - $241.72 $68,637 - $75,658
-313 Reduced 20.36%
1,224 $286,000
Q1 2019

May 01, 2019

SELL
$216.71 - $338.96 $1.55 Million - $2.42 Million
-7,153 Reduced 82.31%
1,537 $363,000
Q4 2018

Feb 04, 2019

BUY
$278.5 - $352.75 $882,009 - $1.12 Million
3,167 Added 57.34%
8,690 $2.62 Million
Q3 2018

Oct 25, 2018

BUY
$293.51 - $383.83 $1.07 Million - $1.4 Million
3,638 Added 193.0%
5,523 $1.95 Million
Q2 2018

Aug 02, 2018

BUY
$257.52 - $306.91 $21,374 - $25,473
83 Added 4.61%
1,885 $547,000
Q2 2018

Jul 25, 2018

SELL
$257.52 - $306.91 $112,021 - $133,505
-435 Reduced 19.45%
1,802 $574,000
Q1 2018

May 01, 2018

BUY
$260.13 - $367.91 $113,156 - $160,040
435 Added 24.14%
2,237 $613,000
Q4 2017

Feb 05, 2018

SELL
$307.64 - $344.58 $60,912 - $68,226
-198 Reduced 9.9%
1,802 $574,000
Q3 2017

Nov 03, 2017

BUY
$281.15 - $329.69 $562,300 - $659,380
2,000
2,000 $626,000

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.